2020 HIVMA HIV primary care guidance continued
Diabetes Type 2 medications and people with HIV
How COVID adapatations may affect PrEP provision…
Update on 2021 DHHS HIV treatment guidelines
Updated 2021 CDC STI treatment guidelines on…
More regulatory changes and important…
USPSTF/CDC updated 2020 recommendations for HCV…
Regulatory changes and important considerations…
Dr. Landovitz discusses HPTN 083, an efficacy…
Overview of Fostemsavir, a recently approved…
HIV PEP/PrEP case scenarios
2020 IAS-USA HIV prevention guidelines update
nPEP guidelines, access barriers, and potential…
2020 IAS-USA HIV treatment guidelines update
2020 CROI highlights on ART safety and side…
Update on 2019 DHHS gudielines on 2-Drug and…
Highlights of DHHS 2020 interim guidance on COVID…